WINDLAS BIOTECH
|
The Current P/S Ratio of WINDLAS BIOTECH is 2.16.
| Share Price | ₹948.0 | Oct 09,2026 |
| Market Cap | ₹1,952.8 Cr | |
| Sales-TTM | ₹904.1 Cr | TTM-Consolidated Results |
| Price/Sales | 2.16x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of WINDLAS BIOTECH
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹1,952.8 Cr] as on Oct 09,2026
(/) Sales [ ₹904.1 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 2.16x ]
Thus, for WINDLAS BIOTECH , the investors are currently willing to pay '2.16 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of WINDLAS BIOTECH !
The chart below summarizes the trend in P/S Ratio of WINDLAS BIOTECH over the last five years.
Historical PS (Price/Sales) ratio chart of WINDLAS BIOTECH
PS Ratio Performance Analysis for WINDLAS BIOTECH
- WINDLAS BIOTECH 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 1.64x.
- WINDLAS BIOTECH 's operated at median p/e ratio of 1.69x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, WINDLAS BIOTECH 's p/e ratio peaked in Mar2025 at 2.87x.
- WINDLAS BIOTECH 's p/e ratio hit its five-year low in Mar2023 of 0.92x.
How does WINDLAS BIOTECH 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| WINDLAS BIOTECH | 904.1 | 2.16 | 1,952.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.04 | 421,539.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 22.05 | 247,576.0 |
| TORRENT PHARMACEUTICALS LTD | 15,723.0 | 11.27 | 177,251.0 |
| CIPLA LTD | 28,324.4 | 3.72 | 105,290.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 3.00 | 99,752.6 |
| MANKIND PHARMA LTD | 14,737.9 | 6.64 | 97,850.4 |
| LUPIN LTD | 29,966.6 | 2.99 | 89,628.8 |
| ZYDUS LIFESCIENCES LTD | 28,591.7 | 3.89 | 111,232.0 |
| AUROBINDO PHARMA LTD | 34,935.3 | 2.78 | 97,014.5 |
| LAURUS LABS LTD | 7,269.6 | 15.10 | 109,797.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs WINDLAS BIOTECH 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.16x |
| Max industry PS | 22.05x |
| Median industry PS | 3.89x |
| Average industry PS | 7.33x |
You may also like the below Video Courses